BIOGENEX APPROVED TO SELL BREAST CANCER DIAGNOSTIC KIT

BioGenex Laboratories has won approval from federal regulators to sell a diagnostic kit that would help doctors determine which breast cancer patients are eligible for treatment with the Genentech drug Herceptin.

East Bay Business Times (http://www.bizjournals.com/eastbay/stories/2005/01/17/daily12.html)